• No products in the cart.

  • LOGIN
CLP100: ICI LUNG CANCER PRECEPTORSHIP

CLP100: [UNIT: 050420]:[A1]: Comment on Criteria for Lung Cancer Screening and the Screening options in low resource settings

Describe the challenges you face in your clinical practice while screening for lung cancer and optimal preventive methods that can …

5Maximum Marks

ENDED Time Remaining Hours Minutes

Top Rated Course

Course Reviews

  • CLP100: ICI LUNG CANCER PRECEPTORSHIP

    Excellent course 5

    Excellent course
  • CSP100: ICI SICKLE CELL DISEASE PRECEPTORSHIP

    5

    Very informative. Thank you.
    Hilda odeny
  • CMP100: ICI MULTIPLE MYELOMA PRECEPTORSHIP

    The Role of Pathology in Multiple Myeloma 5

    Teresa Lotodo gave a good introduction to this lecture by defining MM and other plasma dyscrasias. She dwelt on diagnosis, risk stratification, staging and monitoring of MM. Of interest to me was her discourse on IHC and FISH. The use of CD markers to identify the clonality of the abnormal plasma cells. She also discussed bone marrow aspiration, indications, possible sites, processing of tissues, preparation of slides and reading of the slides by pathologists. There were pictures and charts to aid understanding of her lectures. It was well delivered and I learnt a lot. Thank you.
    Dr. Angela Ogechukwu Ugwu
  • CSP100: ICI SICKLE CELL DISEASE PRECEPTORSHIP

    5

    Its a helpful platform for learning
    Hellen moraa patrick
  • CBP100: ICI BREAST CANCER PRECEPTORSHIP

    Well covered 4

    In depth coverage of the topic was done, with good organization and a variety of experts involved in the care of breast cancer patient. The course also had a good balance between local and worldwide data and practices. Consider group discussion on real life patients amongst fellow course participants in future.
top
© 2022 International Cancer Institute. All Rights Reserved
International Cancer Institute Elearning
X